Streetbeat News

Revenues

NABL

N-Able has projected its FY23 revenue to be between $419.5M and $421M, which is higher than the estimated $415.73M. The company also expects its adjusted EBITDA to be between $135.5M and $137M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:37 pm

ARQT

Arcutis Biotherapeutics has entered into a strategic collaboration and licensing agreement with Huadong Medicine for the development and commercialization of topical Roflumilast in Greater China and Southeast Asia. Arcutis will receive an upfront payment of $30 million and is eligible for additional development and commercial milestone payments, as well as double-digit tiered royalties.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:19 pm

KULR

KULR Technology Group Inc. has announced preliminary Q2 revenue of $2.5M-$2.8M, marking a 300% increase year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:09 pm

URGN

UroGen Pharma Ltd has reiterated its FY23 revenue forecast to be between $76M and $86M, which is slightly below the estimated $80.74M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 12:07 pm

LYFT

Lyft is expanding its advertising business by introducing new ad products and serving display ads on its app. The company also plans to incorporate video ads and expand other ad products such as in-car screens. This move comes as Lyft and its competitor Uber have seen gains from their advertising businesses. Lyft's ad revenue grew 400% YoY in Q2, but the company has not disclosed the exact figures. The company has partnered with adtech company Rokt and measurement firm Kantar to enhance its advertising business.

Portfolio Pulse from Happy Mohamed

August 10, 2023 | 12:03 pm

BRAG

Bragg Gaming has updated its 2023 guidance range, with midpoints implying a revenue growth of 13%. The company now expects revenue to be between $104.5M and $106.7M, up from the previous range of $102.2M to $106.6M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:41 am

HLLY

Holley has increased its revenue outlook for FY23 from $625M-$675M to $635M-$675M, compared to the estimated $659.07M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:35 am

OPTN

OptiNose, Inc. has updated its forecast for FY23 XHANCE net revenues to $64M-$70M, up from the previous estimate of $62M-$68M. The company also expects the average net revenue per prescription to be around $200.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:18 am

DCBO

Docebo has projected its Q3 revenue to be between $45.9M and $46.1M, which is higher than the estimated $45.41M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:13 am

QBTS

D-Wave Quantum has reiterated its FY23 revenue forecast of $11M-$13M, which is in line with the estimated $12.25M.

Portfolio Pulse from Benzinga Newsdesk

August 10, 2023 | 11:07 am